Browsing by Author White, Harvey D

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 10 of 10
Issue DateTitleAuthor(s)Citation
2002Cholesterol-lowering therapy with pravastatin in patients with average cholesterol levels and establisheed ischaemic heart disease: is it cost effective?Eckermann, Simon; Kirby, Adrienne; Martin, Andrew; Mulray, Sarah; Simes, Robert John; Caleo, Susan; Glasziou, Paul P; Hall, Jane P; Tonkin, Andrew M; White, Harvey D; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; Clinical Schools; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreCholesterol-lowering therapy with pravastatin in patients with average cholesterol levels and establisheed ischaemic heart disease: is it cost effective?, Medical Journal of Australia, vol.177,(8),2002,pp 428-434
2003Depression and cardiovascular morbidity and mortality: cause or consequence?Simes, Robert John; Colquhoun, David; North, Fiona M.; Sharples, Katrina J.; Stewart, Ralph A.H.; Tonkin, Andrew M; West, Teena M.; White, Harvey D; School of Public Health: NH&MRC Clinical Trials CentreDepression and cardiovascular morbidity and mortality: cause or consequence?, European Heart Journal, vol.24,(N/A),2003,pp 2027-2037
2002The failure of orally administered glycoprotein IIb/IIIa inhibitors to prevent recurrent cardiac eventsSimes, Robert John; Armstrong, Paul K.; Califf, Robert M; Granger, Christopher B; Harrington, Robert A; Hasselblad, Vic; Newby, L Kristin; Van de Werf, Frans; White, Harvey D; School of Public Health: NH&MRC Clinical Trials CentreThe failure of orally administered glycoprotein IIb/IIIa inhibitors to prevent recurrent cardiac events, American Journal Of Medicine, vol.112,(8),2002,pp 647-658
2006Outcomes of patients in clinical trials with ST-segment elevation myocardial infarction among countries with different gross national incomes.Simes, Robert John; Armstrong, Paul W; Boersma, Eric; Califf, Robert M.; Díaz, Rafael; Granger, Christopher; Harrington, Robert A.; Orlandini, Andres; Paolasso, Ernesto; Pieper, Karen; Van De Werf, Frans J J; White, Harvey D; Wojdyla, Daniel; School of Public Health: NH&MRC Clinical Trials CentreOutcomes of patients in clinical trials with ST-segment elevation myocardial infarction among countries with different gross national incomes., European Heart Journal (2005), vol.27,(5),2006,pp 527-533
2005Patients With Prolonged Ischemic Chest Pain and Presumed-New Left Bundle Branch Block Have Heterogeneous Outcomes Depending on the Presence of ST-Segment ChangesSimes, Robert John; Armstrong, Paul W; Aylward, Philip E G; Califf, Robert M; French, John K; Gao, Wanzhen; Granger, Christopher B; Raffel, O Christopher; Stewart, Ralph A H; Van De Werf, Frans J J; White, Harvey D; Wong, Cheuk-Kit; School of Public Health: NH&MRC Clinical Trials CentrePatients With Prolonged Ischemic Chest Pain and Presumed-New Left Bundle Branch Block Have Heterogeneous Outcomes Depending on the Presence of ST-Segment Changes, Journal of the American College of Cardiology 2005, vol.46,(1),2005,pp 29-38
2017Persistent psychological distress and mortality in patients with stable coronary artery diseaseGlozier, Nicholas; Kirby, Adrienne; Marschner, Simone; Simes, Robert John; Colquhoun, David; Nestel, P; O'Neil, Adrienne; Oldenburg, Brian F.; Stewart, Ralph; Tonkin, Andrew; White, Harvey D; Central Clinical School: Psychological Medicine; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentrePersistent psychological distress and mortality in patients with stable coronary artery disease, Heart, vol.103, 23, 2017,pp 1860-1866
2002Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trialsSimes, Robert John; Armstrong, Paul W; Boersma, Eric; Califf, Robert M; Harrington, Robert A; Moliterno, David J; Simoons, Maarten L.; Theroux, Pierre; Topol, Eric J; Torbal, Anneke de; Van de Werf, Frans; Wallentin, Lars C; White, Harvey D; Wilcox, Robert G; School of Public Health: NH&MRC Clinical Trials CentrePlatelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials, The Lancet, vol.359,(9302),2002,pp 189-198
2002Risk factors for non-haemorraghic stroke in patients with coronary heart disease and the effect of lipid-modifying therapy with pravastatinKirby, Adrienne; Simes, Robert John; Simes, Susan; Watson, John; Anderson, Neil E; Hankey, Graeme J; Hunt, David; Tonkin, Andrew M; West, Malcolm J; White, Harvey D; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; Northern Clinical School: MedicineRisk factors for non-haemorraghic stroke in patients with coronary heart disease and the effect of lipid-modifying therapy with pravastatin, Journal of Hypertension, vol.20,(12),2002,pp 2513-2517
2002Sustained ventricular arrythmias among patients with acute coronary syndromes with no ST-segment elevation: incidence, predictors and outcomesSimes, Robert John; Al-Khatib, Sana M; Armstrong, Paul W; Califf, Robert M; Granger, Christopher B; Harrington, Robert A; Huang, Yao; Lee, Kerry L; Moliterno, David J; Simoons, Maarten L.; Topol, Eric J; Van de Werf, Frans; White, Harvey D; School of Public Health: NH&MRC Clinical Trials CentreSustained ventricular arrythmias among patients with acute coronary syndromes with no ST-segment elevation: incidence, predictors and outcomes, Circulation (Baltimore), vol.106,(3),2002,pp 309-312
2005White Blood Cell Count Predicts Reduction in Coronary Heart Disease Mortality With PravastatinHeritier, Stephane; Kirby, Adrienne; Simes, Robert John; Colquhoun, David M.; Nestel, Paul; Stewart, Ralph A H; Tonkin, Andrew; West, Malcolm; White, Harvey D; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreWhite Blood Cell Count Predicts Reduction in Coronary Heart Disease Mortality With Pravastatin, Circulation 2005, vol.111,(14),2005,pp 1756-1762